Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis
Open Access
- 24 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 19 (1) , 59
Abstract
The latest 8th edition of the AJCC staging system emphasizes the importance of tumor size however, the clinical significance of the combination of tumor location with tumor size remains unknown. We conducted this study to investigate the prognostic role of tumor location in T1 resectable pancreatic ductal adenocarcinoma (PDAC). Resectable PDAC patients from Surveillance, Epidemiology, and End Results (SEER) database (2004–2014) were selected for the propensity score matching analysis. We used matched cohort to analyze the relationship between clinicopathologic features and survival of patients. Eight thousand, four hundred nine patients were included in the propensity score matching analysis and 4571 patients were selected for final analysis. In T1 patients, the patients with pancreatic head tumor had worse prognosis compared to the patients with body/tail tumors. Multivariate analysis result showed that pancreatic body/tail location was an independent indicator for better chances of survival in T1 PDAC patients (hazard ratio, 0.69; 95%CI, 0.52–0.93; P = 0.01). The modified staging system was more efficient than the AJCC 8th staging system. Modified staging system exhibited a good assessment of the survival rate. The tumor location is a good prognostic indicator for T1 resectable PDAC patients. Modification of T1 subgroup according to tumor location exhibited favorable survival prediction effects.Keywords
Funding Information
- National Natural Science Foundation of China (81372261)
This publication has 33 references indexed in Scilit:
- Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic AdenocarcinomaYonsei Medical Journal, 2013
- Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinomaWorld Journal of Gastrointestinal Oncology, 2012
- Prognostic factors in patients with pancreatic cancerExperimental and Therapeutic Medicine, 2011
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesPLOS Medicine, 2010
- Preoperative Biliary Drainage for Cancer of the Head of the PancreasNew England Journal of Medicine, 2010
- The anatomic location of pancreatic cancer is a prognostic factor for survivalHPB, 2008
- Survival and Prognostic Factors of Unresectable Pancreatic CancerJournal of Clinical Gastroenterology, 2008
- A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methodsJournal of Clinical Epidemiology, 2006
- Distal Pancreatectomy for Resectable Adenocarcinoma of the Body and Tail of the PancreasJournal of Gastrointestinal Surgery, 2005
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984